Clonally identical Hodgkin's disease develops after allogeneic hematopoietic cell transplant for CLL

Bone Marrow Transplantation

Volumn 46, Issue 12, 2011, Pages 1576-1578

  Tseng, D ^a   Jones, C D ^a   Anderson, M ^a   Warnke, R ^a   Zehnder, J L ^a   Miklos, D B ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; CD15 ANTIGEN; CD19 ANTIGEN; CD23 ANTIGEN; CD30 ANTIGEN; CD5 ANTIGEN; CD56 ANTIGEN; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; FLUDARABINE; PREDNISONE; RITUXIMAB; THYMOCYTE ANTIBODY; TRANSCRIPTION FACTOR PAX5; VINCRISTINE;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER STAGING; CANCER THERAPY; CASE REPORT; CD3+ T LYMPHOCYTE; CHRONIC LYMPHATIC LEUKEMIA; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DISEASE ASSOCIATION; DONOR LYMPHOCYTE INFUSION; DRUG RESPONSE; FEMALE; GRAFT VERSUS HOST REACTION; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; LETTER; LEUKEMIA REMISSION; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; LYMPHADENOPATHY; MULTIPLE CYCLE TREATMENT; NATURAL KILLER CELL; PARTIAL MASTECTOMY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REDUCED INTENSITY CONDITIONING; REED STERNBERG CELL;

FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMANS; MIDDLE AGED; RECURRENCE; TRANSPLANTATION, HOMOLOGOUS;

EID: 84856090695     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2010.340     Document Type: Letter

References (10)

1. Lowsky R, Takahashi T, Liu YP, Dejbakhsh-Jones S, Grumet FC, Shizuru JA et al. Protective conditioning for acute graftversus-host disease. N Engl J Med 2005; 353: 1321-1331. (Pubitemid 41362700)
2. Momose H, Jaffe ES, Shin SS, Chen YY, Weiss LM. Chronic lymphocytic leukemia/small lymphocytic lymphoma with Reed-Sternberg-like cells and possible transformation to Hodgkin's disease. Mediation by Epstein-Barr virus. Am J Surg Pathol 1992; 16: 859-867.
3. Williams J, Schned A, Cotelingam JD, Jaffe ES. Chronic lymphocytic leukemia with coexistent Hodgkin's disease. Implications for the origin of the Reed-Sternberg cell. Am J Surg Pathol 1991; 15: 33-42.
4. Kanzler H, Kuppers R, Helmes S, Wacker HH, Chott A, Hansmann ML et al. Hodgkin and Reed-Sternberg-like cells in B-cell chronic lymphocytic leukemia represent the outgrowth of single germinal-center B-cell-derived clones: potential precursors of Hodgkin and Reed-Sternberg cells in Hodgkin's disease. Blood 2000; 95: 1023-1031. (Pubitemid 30062727)
5. Ohno T, Smir BN, Weisenburger DD, Gascoyne RD, Hinrichs SD, Chan WC. Origin of the Hodgkin/Reed-Sternberg cells in chronic lymphocytic leukemia with 'Hodgkin's transformation'. Blood 1998; 91: 1757-1761. (Pubitemid 28110342)
6. Luckey CJ, Bhattacharya D, Goldrath AW, Weissman IL, Benoist C, Mathis D. Memory T and memory B cells share a transcriptional program of self-renewal with long-term hematopoietic stem cells. Proc Natl Acad Sci USA 2006; 103: 3304-3309. (Pubitemid 43346465)
7. Tsang WY, Chan JK, Ng CS. Epstein-Barr virus and Reed-Sternberg-like cells in chronic lymphocytic leukemia. Am J Surg Pathol 1993; 17: 853-854. (Pubitemid 23212020)
8. Park CY, Tseng D, Weissman IL. Cancer stem cell-directed therapies: recent data from the laboratory and clinic. Mol Ther 2009; 17: 219-230.
9. Paules RS, Levedakou EN, Wilson SJ, Innes CL, Rhodes N, Tlsty TD et al. Defective G2 checkpoint function in cells from individuals with familial cancer syndromes. Cancer Res 1995; 55: 1763-1773.
10. Ladetto M, Donovan JW, Harig S, Trojan A, Poor C, Schlossnan R et al. Real-time polymerase chain reaction of immunoglobulin rearrangements for quantitative evaluation of minimal residual disease in multiple myeloma. Biol Blood Marrow Transplant 2000; 6: 241-253.